Products  Chemical Naming  ACD/Name  What's New 


 
Request more information
   

ACD/Name


 

ACD/Name

What's New

 
 
 
  ---   ---   ACD/Name to Structure
  ---   ---   ACD/Name to Structure
  ---   ---   ACD/Name to Structure
    ACD/Name     ACD/Index Name     ACD/Name to Structure
    ACD/Name     ACD/Index Name   ---
    ACD/Name     ACD/Index Name   ---
    ACD/Name   ---   ---

Version 6.0 to 7.0

  1. Improvements in the assignment of sterodescriptors including:
    • Stereo at hetero atoms
    • E/Z stereodescriptors for cyclic systems
    • Absolute, relative, and racemic stereodescriptors, as well as MDL chiral flag
  2. Produce names for various radicals, anionic, and cationic structures previously refused by ACD/Name
  3. Expanded naming of natural and biochemical compounds to include:
    • N-glycosides
    • Epoxy- and cyclo-modifications of natural parents
    • Cyclic peptides

1. Improvements in Assignment of Stereodescriptors

Stereo Protocol
Assigning stereodescriptors to a compound is a complex task, especially when it is done manually. The new version of ACD/Name includes the option to show an explanation of the assignment for any stereodescriptor within the generated systematic name, which allows the user to become an expert in the field.

Support of Stereo at Hetero Atoms
ACD/Name supports an assignment of stereodescriptors to phosphorus, sulfur, and arsenic atoms.

IUPAC
Name
(2R,6S)-2-chloro-4,4,5,5-tetramethyl-
6-phenyl-1,3,2-dioxaphosphinane
(2R,3S)-1-[(R)-phenylsulfinyl]butane-2,3-diol
 
Index
Name
1,3,2-dioxaphosphorinane, 2-chloro-4,4,5,5-tetramethyl-6-phenyl-, (2R,6S)- 2,3-butanediol, 1-[(R)-phenylsulfinyl]-, (2R,3S)-

Support of E/Z Stereodescriptors for Cyclic Systems
The current version of ACD/Name supports an indication of E/Z configurations of cyclic double bonds for 8-membered rings or larger.



IUPAC Name (1E,5E,8R)-1,5-dimethyl-8-(1-methylethenyl)cyclododeca-1,5-diene
Index Name 1,5-cyclododecadiene, 1,5-dimethyl-8-(1-methylethenyl)-, (1E,5E,8R)-

Support of Absolute, Relative, and Racemic Stereodescriptors,
as well as MDL Chiral Flag

It is quite common that only relative configurations of chiral centers are known, or the substance is a racemic mixture of stereoisomers. ACD/Name allows the user to set special preferences to specify these situations within the generated names.

Another preference option available is the ability to recognize the presence of an "MDL chiral flag" in a structure imported in MOL, SDfile, or ISIS database format, and assign it as having an absolute or relative configuration. If the option is selected, all structures that have an "MDL chiral flag" will be named as having an absolute configuration and all others as having a relative configuration.

IUPAC name Index Name



Absolute (2R,3S,5E)-hept-5-ene-2,3-diol 5-heptene-2,3-diol, (2R,3S,5E)-
Relative rel-(2R,3S,5E)-hept-5-ene-2,3-diol 5-heptene-2,3-diol, (2R,3S,5E)-rel-
Racemic rac-(2R,3S,5E)-hept-5-ene-2,3-diol 5-heptene-2,3-diol, (5E)-

2. Generate Names for Various Radicals, Anionic, and Cationic Structures Previously Refused by ACD/Name

IUPAC Name 3-methylidene-6-
oxabicyclo[3.2.0]hept-4-ylium-2-yl
(phenylsulfinyl)methanide
 
Index Name 6-oxabicyclo[3.2.0]hept-4-ylium-2-yl, 3-methylene- benzene, (methylsulfinyl)-, ion(1-)

3. Expanded Naming of Natural and Biochemical Compounds

ACD/Name 7.0 now includes the following new possibilities:

  • naming of N-glycoside derivatives of heterocycles
  • support of epoxy- and cyclo-modifications of natural parents
  • naming of cyclic peptides
IUPAC Name 1-beta-L-ribofuranosyl-1,5-dihydro-
4H-imidazo[4,5-c]pyridin-4-one
(3beta,5beta,6beta)-5,6-epoxypregnan-3-ol
 
Index Name 4H-imidazo[4,5-c]pyridin-4-one,
1,5-dihydro-1-beta-L-ribofuranosyl-
pregnan-3-ol, 5,6-epoxy-,
(3beta,5beta,6beta)-

IUPAC and
Index Name
cyclo(glycyl-L-prolyl-L-leucylglycyl-L-prolyl-L-leucyl)
TOP

This page was last updated 31 October 2007
 

  Products | Solutions | Support
Online Services | Resources
About Us | Downloads | Events
Site Map | Contact Us
 

 
Copyright © 1996 - 2008 Advanced Chemistry Development     All rights reserved